(267 days)
Not Found
No
The description focuses on the mechanical and electrical aspects of ultrasonic tissue manipulation and coagulation. There is no mention of AI, ML, or any data-driven decision-making processes.
Yes.
This device is used to transect, dissect, and coagulate tissue during surgical procedures for therapeutic outcomes.
No
This device is an ultrasonic surgical system intended for transecting, dissecting, and coagulating tissue, which is a therapeutic function, not diagnostic.
No
The device description clearly outlines multiple hardware components (Generator, Hand Piece, Ultrasonic Shears, foot switch) and describes their physical functions and interactions. While software verification and validation are mentioned, the device is fundamentally a hardware system with integrated software, not a software-only device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to "transect, dissect, and coagulate tissue" during surgical procedures. This is a direct intervention on the patient's body for therapeutic purposes (cutting, sealing blood vessels).
- Device Description: The description details a system that uses ultrasonic energy to physically interact with and alter tissue. This is a surgical tool, not a device used to examine specimens in vitro (outside the body).
- Lack of IVD Characteristics: There is no mention of analyzing biological specimens (blood, urine, tissue samples, etc.) or providing diagnostic information based on such analysis. The device's function is purely procedural.
IVD devices are used to examine specimens obtained from the human body to provide information for the diagnosis, prevention, monitoring, treatment, or alleviation of disease. This Ultrasonic Surgical System does not fit that definition.
N/A
Intended Use / Indications for Use
The Ultrasonic Surgical System is intended to be used to transect, dissect, and coagulate tissue. The instruments are indicated for use in open and endoscopic general surgical procedures where bleeding control and minimal thermal injury to tissue are desired. The instruments allow for the coagulation of vessels (veins and arteries) up to 3 mm in diameter.
Product codes
LFL
Device Description
Ultrasonic Surgical System is an ultrasonic dissection and coagulation system composed of four components: Ultrasonic Generator (HD-CSD01), Hand Piece (HD-CSH01), a disposable Ultrasonic Shears includes 4 shaft lengths (HD-CS-DJ45, HD-CS-DJ36, HD-CS-DJ22, HD-CS-DJ14) and foot switch (HRF-M52).
A disposable Ultrasonic Shears is a sterile component that has undergone EO sterilization, including an ultrasonic horn, jaws, main shaft, axis rotation, handle, operating handle, and control switch. The operating handle is used to open and close the jaws that grip the tissue. The Ultrasonic Surgical System can simultaneously cut and coagulate tissues by setting different output power levels. The high-power range allows for faster tissue cutting, while the low-power range allows for better tissue closure. The ultrasonic frequency current in the ultrasonic generator is transmitted to the hand piece, which converts electrical energy into mechanical energy for forward and backward vibration. Through the transmission and release of the blade, the end of the blade vibrates at a certain frequency. The heat generated by friction causes water vaporization in the tissue cells that come into contact with the blade, protein hydrogen bonds break, cells collapse and the tissue is cut open after solidification; When cutting blood vessels, the knife head contacts with Histone and generates heat through mechanical vibration, leading to the destruction of the collagen structure in the tissue, causing the protein to coagulate, and then sealing the blood vessels to stop bleeding. The disposable ultrasonic shears are EO sterilized, but the other parts are non-sterilized packaging, and the hand piece must be cleaned and sterilized by the user before being used for surgery.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
For use in all patients
Intended User / Care Setting
Users: Healthcare professionals
Environment of Use: Hospital environment, such as surgical operation room and imaging intervention room.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Summary of Non-Clinical Tests
- Sterilization: The Ultrasonic Shears were sterilized via ethylene oxide. The process was validated as per ISO 11135 (overkill method). Ethylene oxide residuals met ISO 10993-7 requirements.
- Biocompatibility Testing: Conducted on the shear for direct contact with body tissue (less than 24 hours). Tests included in vitro cytotoxicity, intracutaneous reactivity, skin sensitization, acute systemic toxicity, and pyrogen, as per FDA guidance ISO 10993-1. Results indicated the device was not toxic, irritating, or sensitizing, and was free of acute systemic toxicity and pyrogen.
- Electrical safety and electromagnetic compatibility (EMC): Complied with IEC 60601-1-2:2020 for EMC, and IEC 60601-1:2020 and IEC 60601-2-18 for electrical safety.
- Performance testing: Functional tests met predetermined acceptance criteria.
- Animal testing: Conducted on porcine model with test articles (Ultrasonic Surgical System) and control article (predicate device Ethicon G11). It consisted of three experiments:
- In vitro burst pressure: Test results showed no statistical difference or higher average burst pressure in the test group compared to the control group. No error or notes observed.
- Acute animal study: Times and thermal damage range for each vessel diameter did not show statistical difference compared to the control article. No sealing failures were identified.
- Chronic Animal Testing: Postoperative observation showed no abnormal phenomena in animals. Gross examination of animals showed no hematoma, bleeding, or other adverse conditions at the sealed site. Few tissues showed moderate inflammatory cell infiltration, most showed few inflammatory cells. Wide fibrosis and mild tissue necrosis were observed at the test site.
- Packaging & Shelf life: Study conducted to ensure package integrity throughout shelf life, including primary packaging validation as per ISO 11607 and shelf life validation as per ASTM F1980.
- Software Verification and Validation: In compliance with FDA Guidance-Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices.
- Cleaning, Disinfection and Sterilization effectiveness: Methods for Hand Piece validated as per ISO 17664-1.
- Cybersecurity: No cybersecurity evaluation needed as the device does not have external interfaces, according to FDA guidance "Content of Premarket Submissions for Management of Cybersecurity in Medical Devices".
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
N/A
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo in blue, with the words "U.S. FOOD & DRUG" on top and "ADMINISTRATION" on the bottom.
June 18, 2024
Hunan Handlike Minimally Invasive Surgery Co., Ltd. % Lee Cassie Official Correspondent Share Info (Guangzhou) Medical Consultant Ltd. No. 1919-1920, Building D3, Minjie Plaza, Shuixi Road, Huangpu District Guangzhou, Guangdong 510700 China
Re: K233036
Trade/Device Name: Ultrasonic Surgical System Regulatory Class: Unclassified Product Code: LFL Dated: May 17, 2024 Received: May 17, 2024
Dear Lee Cassie:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device"
1
(https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review. the OS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Digitally signed by Mark Mark Trumbore -S Trumbore -S Date: 2024.06.18 14:02:02 -04'00' Mark Trumbore, Ph.D. Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality
2
Enclosure
3
Indications for Use
510(k) Number (if known) K233036
Device Name Ultrasonic Surgical System
Indications for Use (Describe)
The Ultrasonic System is intended to be used to transect, dissect, and coagulate tissue. The instruments are indicated for use in open and endoscopic general surgical procedures where bleeding control and minimal thermal injury to tissue are desired. The instruments allow for the coagulation of vessels (veins and arteries) up to 3 mm in diameter.
Type of Use (Select one or both, as applicable) | |
---|---|
Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
510(k) Summary for K233036
Prepared on: 2024-06-13
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirement of 21 CFR 801.92.
1. Submitter's Information
510(k) Owner's Name: Hunan Handlike Minimally Invasive Surgery Co., Ltd. Establishment Registration Number: 3010594949 Address: A4, Lugu Yuyuan, #27, Wenxuan Rd, High-tech Zone Changsha Hunan 410205 China Tel: +(86) 731 89727780 Contact Person: Mr. Yang Bihong E-mail: yang_bh@handlike.cn
Application Correspondent:
Contact Person: Cassie Lee Company: Share Info (Guangzhou) Medical Consultant Ltd. Address: No. 1919-1920, Building D3, Minjie Plaza, Shuixi Road, Huangpu District, Guangzhou, China Tel: +86 20 8266 2446 E-mail: 382198657@qq.com
2. Subject Device Information
Type of 510(k): Traditional Trade Name: Ultrasonic Surgical System Model: HD-CSXT-001 Common Name: Ultrasonic Shears Classification name: Instrument, Ultrasonic Surgical Product Code: LFL Regulation Number: Unclassified
3. Predicate Device Information
Predicate Device 1:
Sponsor: Surgnova Healthcare Technologies (Zhejiang) Co., Ltd. Trade Name: Ultrasonic Scalpel System 510(K) Number: K212614 Classification name: Instrument, Ultrasonic Surgical Product Code: LFL
5
Review Panel: General & Plastic Surgery Requlation Class: Unclassified
Predicate Device 2:
Sponsor: Ethicon Endo-Surgery, LLC Trade Name: HARMONIC Hook 510(K) Number: K151136 Classification name: Instrument, Ultrasonic Surgical Product Code: LFL Review Panel: General & Plastic Surgery Requlation Class: Unclassified
4. Device Description
Ultrasonic Surgical System is an ultrasonic dissection and coagulation system composed of four components: Ultrasonic Generator (HD-CSD01), Hand Piece (HD-CSH01), a disposable Ultrasonic Shears includes 4 shaft lengths (HD-CS-DJ45, HD-CS-DJ36, HD-CS-DJ22, HD-CS-DJ14) and foot switch (HRF-M52).
A disposable Ultrasonic Shears is a sterile component that has undergone EO sterilization, including an ultrasonic horn, jaws, main shaft, axis rotation, handle, operating handle, and control switch. The operating handle is used to open and close the jaws that grip the tissue. The Ultrasonic Surgical System can simultaneously cut and coagulate tissues by setting different output power levels. The high-power range allows for faster tissue cutting, while the low-power range allows for better tissue closure. The ultrasonic frequency current in the ultrasonic generator is transmitted to the hand piece, which converts electrical energy into mechanical energy for forward and backward vibration. Through the transmission and release of the blade, the end of the blade vibrates at a certain frequency. The heat generated by friction causes water vaporization in the tissue cells that come into contact with the blade, protein hydrogen bonds break, cells collapse and the tissue is cut open after solidification; When cutting blood vessels, the knife head contacts with Histone and generates heat through mechanical vibration, leading to the destruction of the collagen structure in the tissue, causing the protein to coagulate, and then sealing the blood vessels to stop bleeding. The disposable ultrasonic shears are EO sterilized, but the other parts are non-sterilized packaging, and the hand piece must be cleaned and sterilized by the user before being used for surgery.
This device is intended to be used in the hospital environment, such as surgical operation room and imaging intervention room.
5. Intended Use / Indications for Use
The Ultrasonic Surgical System is intended to be used to transect, dissect, and coagulate tissue. The instruments are indicated for use in open and endoscopic general surgical
6
procedures where bleeding control and minimal thermal injury to tissue are desired. The instruments allow for the coagulation of vessels (veins and arteries) up to 3 mm in diameter.
6. Comparison to predicate device
6.1 Comparison table for Ultrasonic Generator, transducer and pedal
| Elements of
Comparison | Subject Device | Predicate Device 1 |
---|---|---|
Manufacturer | Hunan Handlike Minimally | |
Invasive Surgery Co., Ltd. | Surgnova Healthcare | |
Technologies (Zhejiang) Co., | ||
Ltd. | ||
Trade Name | Ultrasonic Surgical System | Ultrasonic Scalpel System |
510(k) Number | K233036 | K212614 |
Classification Name | Instrument, Ultrasonic | |
Surgical | Instrument, Ultrasonic | |
Surgical | ||
Classification Product | ||
Code | LFL | LFL |
Indications for Use | The Ultrasonic Surgical | |
System is intended to be | ||
used to transect, dissect, and | ||
coagulate tissue. The | ||
instruments are indicated for | ||
use in open and endoscopic | ||
general surgical procedures | ||
where bleeding control and | ||
minimal thermal injury to | ||
tissue are desired. The | ||
instruments allow for the | ||
coagulation of vessels (veins | ||
and arteries) up to 3 mm in | ||
diameter. | The Ultrasonic Scalpel | |
System is intended to be | ||
used to transect, dissect, and | ||
coagulate tissue. The | ||
instruments are indicated for | ||
use in open and endoscopic | ||
general surgical procedures | ||
where bleeding control and | ||
minimal thermal injury to | ||
tissue are desired. The | ||
instruments allow for the | ||
coagulation of vessels (veins | ||
and arteries) up to 5 mm in | ||
diameter while using the | ||
power level 1. Device have | ||
not been shown to be | ||
effective for sterilization | ||
procedures or tubal | ||
coagulation. Do not use | ||
these instruments for these | ||
procedures. | ||
Working Principle | The Ultrasonic Generator | |
outputs the AC energy at a | ||
resonating frequency of | The generator outputs the AC | |
energy at a resonating | ||
frequency of 55.5KHz to the | ||
Elements of | ||
Comparison | Subject Device | Predicate Device 1 |
55.5KHz to the hand piece, | ||
which transforms it to | ||
mechanical vibrations to | ||
reach the clamped tissue at | ||
the blade tip of the ultrasonic | ||
shears' waveguide. Vibrating | ||
at high frequency, the blade | ||
tip denatures protein in the | ||
tissue to form a sticky | ||
coagulum, with the pressure | ||
exerted on tissue with the | ||
blade surface collapses blood | ||
vessels and allows the | ||
coagulum to form a | ||
hemostatic seal. The | ||
precision of cutting and | ||
coagulation is controlled by | ||
the surgeon's technique and | ||
adjusting the power level, | ||
blade edge, tissue traction | ||
and blade pressure. | ultrasonic transducer, which | |
transforms it to mechanical | ||
vibrations to reach the | ||
clamped tissue at the blade | ||
tip of the ultrasonic scalpel's | ||
waveguide. Vibrating at high | ||
frequency, the blade tip | ||
denatures protein in the | ||
tissue to form a sticky | ||
coagulum, with the pressure | ||
exerted on tissue with the | ||
blade surface collapses blood | ||
vessels and allows the | ||
coagulum to form a | ||
hemostatic seal. The | ||
precision of cutting and | ||
coagulation is controlled by | ||
the surgeon's technique and | ||
adjusting the power level, | ||
blade edge, tissue traction | ||
and blade pressure. | ||
Size (Width x Height x | ||
Depth) | Ultrasonic Generator: 37.0cm | |
x 39.0cm x 16.3cm | Generator: 40.0cm x 40.0cm | |
x 12.0cm | ||
Design | The ultrasonic generator is | |
configured to resonate with | ||
the Hand Piece and scalpel at | ||
a resonant frequency to drive | ||
the scalpel's distal tip to | ||
vibrate at a high frequency. | The generator is configured | |
to resonate with the | ||
transducer and scalpel at a | ||
resonant frequency to drive | ||
the scalpel's distal tip to | ||
vibrate at a high frequency. | ||
Power Source | 110-240V AC, 50/60Hz, 500 | |
VA | 100-240V AC, 50/60Hz, 200 | |
VA | ||
Output Frequency | 55.5KHz | 55.5KHz |
Environment of Use | Hospital environment | Hospital environment |
Patient Population | For use in all patients | For use in all patients |
Users | Healthcare professionals | Healthcare professionals |
Transducer | ||
Product Name | Hand Piece | Ultrasonic Transducer |
Model | HD-CSH01 | SC100T |
Elements of | ||
Comparison | Subject Device | Predicate Device 1 |
Working Principle | The Hand Piece which | |
contains piezoelectric Hand | ||
Pieces that converts | ||
electronic energy into | ||
ultrasonic vibration to power | ||
ultrasonic Shears. | The Ultrasonic Transducer | |
which contains piezoelectric | ||
transducers that converts | ||
electronic energy into | ||
ultrasonic vibration to power | ||
Ultrasonic Scalpel. | ||
Reusable /Single-use | ||
Device | Reusable device | Reusable device |
Reusable times | 95 times | 99 times |
Supply | It is supplied non-sterilize, | |
sterilize prior to use. | It is supplied non-sterilize, | |
sterilize prior to use. | ||
Sterilization method | Low temperature plasma | Pulsation vacuum/Low |
temperature plasma | ||
Foot Switch | ||
Product Name | Foot Switch | Foot Switch |
Model | HRF-M52 | TG-A |
Working Principle | It is connected to the | |
Ultrasonic Generator, can be | ||
used to control the energy | ||
output of the generator by the | ||
users stepping down the foot | ||
switch. | It is connected to the | |
Ultrasonic Generator, can be | ||
used to control the energy | ||
output of the generator by the | ||
users stepping down the foot | ||
switch. | ||
Design features | The left foot switch is used to | |
control the cutting mode; The | ||
right foot switch is used to | ||
control the coagulation mode | Press the left foot pedal of | |
the foot switch is equivalent | ||
to press the hand control MIN | ||
button. Press the right foot | ||
pedal of the foot switch is | ||
equivalent to press the hand | ||
control MAX button. | ||
Reusable /Single-use | ||
Device | Reusable | Reusable |
Sterility | Non-sterile | Non-sterile |
Cleaning and disinfection | Cleaning and disinfection, if | |
foot switch contaminated by | ||
blood or body fluid according | ||
to IFU or the hospital | ||
regulations | Cleaning and disinfection, if | |
foot switch contaminated by | ||
blood or body fluid according | ||
to IFU or the hospital | ||
regulations |
7
8
9
6.2 Comparison table for Ultrasonic Scalpel
| Elements of
Comparison | Subject Device | Predicate Device 1 | Predicate Device 2 |
---|---|---|---|
Manufacturer | Hunan Handlike | ||
Minimally Invasive | |||
Surgery Co., Ltd. | Surgnova Healthcare | ||
Technologies (Zhejiang) | |||
Co., Ltd. | Ethicon Endo- | ||
Surgery, LLC | |||
Trade Name | Ultrasonic Surgical | ||
System | Ultrasonic Scalpel | ||
System | HARMONIC Hook | ||
510(k) Number | Applying | K212614 | K151136 |
Classification Name | Instrument, Ultrasonic | ||
Surgical | Instrument, Ultrasonic | ||
Surgical | Instrument, | ||
Ultrasonic Surgical | |||
Classification | |||
Product | |||
Code | LFL | LFL | LFL |
Indications for Use | The Ultrasonic | ||
Surgical System is | |||
intended to be used to | |||
transect, dissect, and | |||
coagulate tissue. The | |||
instruments are | |||
indicated for use in | |||
open and endoscopic | |||
general surgical | |||
procedures where | |||
bleeding control and | |||
minimal thermal injury | |||
to tissue are desired. | |||
The instruments allow | |||
for the coagulation of | |||
vessels (veins and | |||
arteries) up to 3 mm in | |||
diameter. | The Ultrasonic Scalpel | ||
System is intended to be | |||
used to transect, | |||
dissect, and coagulate | |||
tissue. The instruments | |||
are indicated for use in | |||
open and endoscopic | |||
general surgical | |||
procedures where | |||
bleeding control and | |||
minimal thermal injury to | |||
tissue are desired. The | |||
instruments allow for the | |||
coagulation of vessels | |||
(veins and arteries) up | |||
to 5 mm in diameter | |||
while using the power | |||
level 1. Device have not | |||
been shown to be | |||
effective for sterilization | |||
procedures or tubal | |||
coagulation. Do not use | |||
these instruments for | |||
these procedures. | The HARMONIC | ||
Hook instrument is | |||
indicated for soft | |||
tissue incisions when | |||
bleeding control and | |||
minimal thermal | |||
injury are desired. | |||
The instrument can | |||
be used as an | |||
adjunct to or | |||
substitute for | |||
electrosurgery, | |||
lasers, and steel | |||
scalpels in general, | |||
plastic, gynecologic, | |||
exposure to | |||
orthopedic structures | |||
(such as spine and | |||
joint space), and | |||
thoracic surgery, | |||
including mobilization | |||
of the Internal | |||
Mammary Artery | |||
(IMA). | |||
Product Name | Ultrasonic Shears | Ultrasonic Scalpel | HARMONIC Hook |
Model | HD-CS-DJ14 | SC43C+ | -- |
Elements of | |||
Comparison | Subject Device | Predicate Device 1 | Predicate Device 2 |
HD-CS-DJ22 | |||
HD-CS-DJ36 | |||
HD-CS-DJ45 | SC35C+ | ||
SC21C+ | |||
SC13C+ | |||
Shaft Length (cm) | HD-CS-DJ14: 14cm | ||
±10% | |||
HD-CS-DJ22: 23cm | |||
±10% | |||
HD-CS-DJ36: 36 cm | |||
±10% | |||
HD-CS-DJ45:45 cm | |||
±10% | SC43C+: 43cm | ||
SC35C+: 35cm | |||
SC21C+: 21cm | |||
SC13C+: 13cm | 32 cm | ||
Working Principle | The Hand Piece | ||
connects the | |||
Ultrasonic Generator | |||
and the Disposable | |||
Ultrasonic Shears | |||
together. It converts | |||
electrical energy from | |||
the ultrasonic | |||
Generator into | |||
mechanical vibrations | |||
and transmits them to | |||
the waveguide of the | |||
scalpel. The scalpel | |||
transmits the | |||
vibrations from the | |||
Ultrasonic Hand Piece | |||
to the clamped soft | |||
tissues for dissection | |||
and coagulation | The Ultrasonic | ||
Transducer connects | |||
the Ultrasonic Generator | |||
and the Ultrasonic | |||
Scalpel together. It | |||
converts electrical | |||
energy from the | |||
generator into | |||
mechanical vibrations | |||
and transmits them to | |||
the waveguide of the | |||
scalpel. The scalpel | |||
transmits the vibrations | |||
from the Ultrasonic | |||
Transducer to the | |||
clamped soft tissues for | |||
dissection and | |||
coagulation | The HPBLUE | ||
handpiece connects | |||
the HARMONIC | |||
Hook device to the | |||
Generator G11, and | |||
converts electrical | |||
energy into | |||
mechanical motion | |||
(ultrasonic energy). | |||
The high-frequency | |||
mechanical vibration | |||
at 55.5 kHz of the | |||
HARMONIC Hook | |||
blade transects, | |||
dissects, and | |||
coagulates tissue, | |||
sealing vessels up to | |||
2 mm | |||
Description of | |||
function | Ultrasonic Shears is | ||
sterile, single patient | |||
use instruments | |||
consisting of an | |||
ergonomic grip | |||
housing assembly with | |||
hand control buttons | Ultrasonic Scalpel is | ||
sterile, single patient | |||
use instruments | |||
consisting of an | |||
ergonomic grip housing | |||
assembly with hand | |||
control buttons | Not public | ||
Elements of | |||
Comparison | Subject Device | Predicate Device 1 | Predicate Device 2 |
Description of | |||
power level | The MAX button is | ||
typically used for | |||
smaller vessels where | |||
cutting speed is | |||
fastest. The MIN | |||
button at power level 1 | |||
is typically used in | |||
larger vessels and has | |||
reduced cutting speed. | |||
It is indicated for | |||
vessels up to 3 mm in | |||
diameter. | The MAX button is | ||
typically used for smaller | |||
vessels where cutting | |||
speed is fastest. The | |||
MIN button at power | |||
level 1 is typically used | |||
in larger vessels and | |||
has reduced cutting | |||
speed. It is indicated for | |||
vessels up to 5 mm in | |||
diameter. | The instrument | ||
allows for the cutting | |||
of soft tissue and | |||
coagulation of | |||
vessels up to and | |||
including 2 mm in | |||
diameter. | |||
Tissue self- | |||
adjustment | |||
technology | Energy timely | ||
adjustment technology | |||
provides the generator | |||
with the ability to | |||
monitor the real-time | |||
impedance during use | |||
so that the generator | |||
auto adjusts the power | |||
output and delivers it | |||
to the Ultrasonic | |||
Shears, as well as | |||
provides audible | |||
feedback to the user. | Energy timely | ||
adjustment technology | |||
provides the generator | |||
with the ability to | |||
monitor the real-time | |||
impedance during use | |||
so that the generator | |||
auto adjusts the power | |||
output and delivers it to | |||
the ultrasonic scalpel, as | |||
well as provides audible | |||
feedback to the user. | Not public | ||
Outer Diameter | |||
(mm) | 5.5 mm | 5.5 mm | Not public |
Blade frequency | 55.5KHz | 55.5KHz | 55.5KHz |
Blade amplitude | (50-70) ±15μm | 50~100 μm | Not public |
Blade | |||
design/geometry | Multi-purpose shears | Multi-purpose shears | Not public |
Handle type | Pistol Grip | Pistol Grip | Not public |
Energy activation | |||
method | Press Max/Min button | Press Max/Min button | Not public |
Indicated vessel type | Veins and arteries | Veins and arteries | Not public |
Energy buttons | Max/Min | Max/Min | Not public |
Design | The device utilizes | ||
ultrasonic energy to | The device utilizes | ||
ultrasonic energy to | The device utilizes | ||
ultrasonic energy to | |||
Elements of | |||
Comparison | Subject Device | Predicate Device 1 | Predicate Device 2 |
enable hemostatic | |||
cutting and/or | |||
coagulation of soft | |||
tissue | enable hemostatic | ||
cutting and/or | |||
coagulation of soft | |||
tissue | enable hemostatic | ||
cutting and/or | |||
coagulation of soft | |||
tissue | |||
Human Tissue or | |||
Body Fluids in | |||
Contact with the | |||
Device | Tissue | Tissue | Tissue |
10
11
12
7. Test Summary
7.1 Summary of Non-Clinical Tests
Ultrasonic Surgical System has been evaluated the safety and performance by lab bench testing as following:
-
Sterilization
The Ultrasonic Shears, which was single use, was sterilized via ethylene oxide. The Ethylene oxide sterilization process is validated as per ISO 11135. The method used for ethylene oxide sterilization validation was overkill (half-cycle approach) method in a fixed chamber. Ethylene oxide residuals were tested and met ISO 10993-7 requirements.
Biocompatibility Testing
The Ultrasonic Shears is in direct contact with body tissue, with contact duration of less than 24 hours. Biocompatibility testing was conducted on the shear in question on 5 tests of in vitro cytotoxicity, intracutaneous reactivity, skin sensitization, acute systemic toxicity and pyrogen as per FDA quidance Use of international Standard ISO 10993-1, which indicated that the device was not toxic, irritating or sensitizing, and was free of acute systemic toxicity and pyrogen.
- A Electrical safety and electromagnetic compatibility (EMC)
Electrical safety and EMC testing were conducted on the proposed device. The system was shown to comply with IEC 60601-1-2:2020 for electromagnetic compatibility, IEC 60601-1:2020 and IEC 60601-2-18 for electrical safety.
A Performance testing
Performance test and functional tests were conducted on the proposed device in accordance with product design specifications. Data generated from the test met the predetermined acceptance criteria.
A Animal testing
The animal study was conducted on porcine model with test articles (Ultrasonic Surgical System) and control article (predicate device Ethicon G11). It consisted of three experiments, in vitro burst pressure, acute animal experiment and 21-day chronic animal's experiment. The
13
experiments results show that the safety and efficacy of the tested articles are similar to those of the control articles.
■ Burst pressure testing
The test results demonstrated that either there was no statistical difference of burst pressure between test group and control group or the average burst pressure of test group was higher than that of the control group where there was statistical difference. There was no error or note observed during the in vitro burst experiment. Therefore, the results were deemed as acceptable.
-
Acute animal study
The test results demonstrated the times and thermal damage range of test article of each vessel diameter range did not have statistical difference compared with those of control article. There was no failure of sealing identified during all sealings after first activation and after challenge. -
. Chronic Animal Testing
Postoperative observation showed no abnormal phenomena in respiration, muscle movement,spasm, reflex, eye symptoms, salivation, hair standing, pain loss, muscle state, gastrointestinal condition, and skin condition in all animals. The gross examination of each animal demonstrated that there was no hematoma, bleeding or any other adverse condition of the sealed site. Few tissues showed moderate inflammatory cell infiltration, while most tissues showed a small number of inflammatory cells. There was wide fibrosis and mild tissue necrosis at the test site.
A Packaging & Shelf life
The packaging and shelf life study was also conducted to ensure package integrity throughout the shelf life, including primary packaging validation as per ISO 11607 and shelf life validation as per ASTM F1980.
-
♪ Software Verification and Validation
The Software verification and validation is in compliance with FDA Guidance-Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices. -
♪ Cleaning, Disinfection and Sterilization effectiveness
The methods for cleaning, disinfection, and sterilization of Hand Piece have been validated as per ISO 17664-1.
A Cybersecurity
The subject device does not have any external interfaces, according to FDA guidance "Content of Premarket Submissions for Management of Cybersecurity in Medical Devices", no need cybersecurity evaluation.
8. Final Conclusion:
The subject device Ultrasonic Surgical System has technological characteristics similar to the predicate device. Performance testing demonstrated that the differences do not affect the safety and effectiveness of the subject device. Thus, the subject device is substantially
14
equivalent to the predicate devices K212614 and K151136 in terms of safety and effectiveness for requested indications for use.